title: Prolonged progression-free survival in a patient with triple-negative breast cancer metastatic to the liver after chemotherapy and local radiation therapy.
authors.affiliation: Department of Radiation Oncology, Yale University School of Medicine, New Haven, CT. Electronic address: bryan.chang@yale.edu.
authors.forename: Bryan
authors.initials: B
authors.lastname: Chang
authors.affiliation: Department of Medicine, Yale University School of Medicine, New Haven, CT.
authors.forename: Joseph
authors.initials: J
authors.lastname: Sokhn
authors.affiliation: Section of Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT.
authors.forename: Edward
authors.initials: E
authors.lastname: James
authors.affiliation: Section of Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT.
authors.forename: Maysa
authors.initials: M
authors.lastname: Abu-Khalaf
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068258:Bevacizumab; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D059248:Chemoradiotherapy; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality* / Q000473:pathology / Q000556:secondary; D008875:Middle Aged; D060787:Neoplasm Grading; D017239:Paclitaxel / Q000008:administration & dosage; D011379:Prognosis; D015996:Survival Rate; D064726:Triple Negative Breast Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D017239:Paclitaxel
keywords: Chemotherapy; Liver metastasis; Radiation; Stereotactic body radiation therapy; Triple negative breast cancer